Department of Vascular Surgery, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
J Vasc Surg. 2011 Oct;54(4):1175-81. doi: 10.1016/j.jvs.2011.02.065. Epub 2011 Aug 6.
Abdominal aortic aneurysms (AAAs) and abdominal wall hernias represent chronic degenerative conditions. Both aortic aneurysms and inguinal hernias share common epidemiologic features, and several investigators have found an increased propensity for hernia development in patients treated for aortic aneurysms. Chronic inflammation and dysregulation in connective tissue metabolism constitute underlying biological processes, whereas genetic influences appear to be independently associated with both disease states. A literature review was conducted to identify all published evidence correlating aneurysms and hernias to a common pathology.
PubMed/Medline was searched for studies investigating the clinical, biochemical, and genetic associations of AAAs and abdominal wall hernias. The literature was searched using the MeSH terms "aortic aneurysm, abdominal," "hernia, inguinal," "hernia, ventral," "collagen," "connective tissue," "matrix metalloproteinases," and "genetics" in all possible combinations. An evaluation, analysis, and critical overview of current clinical data and pathogenic mechanisms suggesting an association between aneurysms and hernias were undertaken.
Ample evidence lending support to the clinical correlation between AAAs and abdominal wall hernias exists. Pooled analysis demonstrated that patients undergoing aortic aneurysm repair through a midline abdominal incision have a 2.9-fold increased risk of developing a postoperative incisional hernia compared with patients treated for aortoiliac occlusive disease (odds ratio, 2.86; 95% confidence interval, 1.97-4.16; P < .00001), whereas the risk of inguinal hernia was 2.3 (odds ratio, 2.30; 95% confidence interval, 1.52-3.48; P < .0001). Emerging evidence has identified inguinal hernia as an independent risk factor for aneurysm development. Although mechanisms of extracellular matrix remodeling and the imbalance between connective tissue degrading enzymes and their inhibitors instigating inflammatory responses have separately been described for both disease states, comparative studies investigating these biological processes in aneurysm and hernia populations are scarce. A genetic predisposition has been documented in familial and observational segregation studies; however, the pertinent literature lacks sufficient supporting evidence for a common genetic basis for aneurysm and hernia.
Insufficient data are currently available to support a systemic connective tissue defect affecting the structural integrity of the aortic and abdominal wall. Future investigations may elucidate obscure aspects of aneurysm and hernia pathophysiology and create novel targets for pharmaceutical and gene strategies for disease prevention and treatment.
腹主动脉瘤(AAA)和腹壁疝代表慢性退行性疾病。主动脉瘤和腹股沟疝都具有共同的流行病学特征,一些研究人员发现,在接受主动脉瘤治疗的患者中,疝的发生倾向增加。慢性炎症和结缔组织代谢失调构成了潜在的生物学过程,而遗传影响似乎与这两种疾病状态都有独立的关联。进行了文献综述,以确定所有发表的证据将动脉瘤和疝与共同的病理学联系起来。
在 PubMed/Medline 中搜索研究 AAA 和腹壁疝的临床、生化和遗传关联的研究。使用 MeSH 术语“腹主动脉瘤,腹部”、“疝,腹股沟”、“疝,腹侧”、“胶原”、“结缔组织”、“基质金属蛋白酶”和“遗传学”,以所有可能的组合搜索文献。对目前临床数据和发病机制的评估、分析和批判性综述表明,动脉瘤和疝之间存在关联。
大量证据支持 AAA 和腹壁疝之间的临床相关性。汇总分析表明,与接受腹主动脉瘤修复的患者相比,通过中线腹部切口进行主动脉瘤修复的患者术后切口疝的风险增加 2.9 倍,而接受腹主动脉髂动脉闭塞性疾病治疗的患者为 2.86(比值比,2.86;95%置信区间,1.97-4.16;P <.00001),而腹股沟疝的风险为 2.3(比值比,2.30;95%置信区间,1.52-3.48;P <.0001)。新出现的证据表明腹股沟疝是动脉瘤发展的独立危险因素。尽管细胞外基质重塑机制以及连接组织降解酶与其抑制剂之间的平衡引发炎症反应已分别针对这两种疾病状态进行了描述,但比较研究在动脉瘤和疝人群中调查这些生物学过程的研究很少。家族性和观察性分离研究已经记录了遗传易感性;然而,相关文献缺乏支持动脉瘤和疝具有共同遗传基础的充分证据。
目前的数据不足以支持影响主动脉和腹壁结构完整性的系统性结缔组织缺陷。未来的研究可能会阐明动脉瘤和疝病理生理学的模糊方面,并为疾病预防和治疗的药物和基因策略创造新的靶点。